{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:30:53Z","timestamp":1761895853010},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T00:00:00Z","timestamp":1396483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s13277-014-1889-x","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T14:24:01Z","timestamp":1396448641000},"page":"6601-6605","source":"Crossref","is-referenced-by-count":39,"title":["Bladder cancer invasion predictability based on preoperative neutrophil\u2013lymphocyte ratio"],"prefix":"10.1007","volume":"35","author":[{"given":"Mehmet","family":"Kaynar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Erol","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00fcseyin","family":"Badem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00fccahit","family":"\u00c7avi\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdem","family":"Tekinarslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa Okan","family":"\u0130stanbulluo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6mer Faruk","family":"Karata\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ersin","family":"\u00c7imentepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,3]]},"reference":[{"key":"1889_CR1","unstructured":"Witjes JA, Comp\u00e9rat E, Cowan NC, De Santis M, Gakis G, Lebret T el al. Guidelines on muscle-invasive and metastatic bladder cancer. EAU Guideline 2013;1-82."},{"key":"1889_CR2","unstructured":"Sobin LH, Gospodariwicz M, Wittekind C, editors. TNM classification of malignant tumors. UICC International Union Against Cancer, ed. 7. Hoboken: Wiley-Blackwell; 2009. p. 262\u20135."},{"issue":"6","key":"1889_CR3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.eururo.2005.03.014","volume":"47","author":"BW Rhijn Van","year":"2005","unstructured":"Van Rhijn BW, van der Poel HG, van der Kwast TH. Urine markers for bladder cancer surveillance: a systematic review. Eur Urol. 2005;47(6):736\u201348.","journal-title":"Eur Urol"},{"issue":"1","key":"1889_CR4","first-page":"5","volume":"102","author":"R Zahorec","year":"2001","unstructured":"Zahorec R. Ratio of neutrophil to lymphocyte counts\u2014rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5\u201314.","journal-title":"Bratisl Lek Listy"},{"issue":"1","key":"1889_CR5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/fon.09.136","volume":"6","author":"CS Roxburgh","year":"2010","unstructured":"Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6(1):149\u201363.","journal-title":"Future Oncol"},{"issue":"3","key":"1889_CR6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/clpt.2011.122","volume":"90","author":"SJ Clarke","year":"2011","unstructured":"Clarke SJ, Chua W, Moore M, Kao S, Phan V, Tan C, et al. Use of inflammatory markers to guide cancer treatment. Clin Pharmacol Ther. 2011;90(3):475\u20138.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"1889_CR7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jso.20329","volume":"91","author":"SR Walsh","year":"2005","unstructured":"Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91(3):181\u20134.","journal-title":"J Surg Oncol"},{"issue":"1","key":"1889_CR8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00262-008-0516-3","volume":"58","author":"H Cho","year":"2009","unstructured":"Cho H, Hur HW, Kim SW, Kim SH, Kim JH, Kim YT, et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother. 2009;58(1):15\u201323.","journal-title":"Cancer Immunol Immunother"},{"issue":"23","key":"1889_CR9","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1158\/1078-0432.CCR-10-2245","volume":"16","author":"SC Kao","year":"2010","unstructured":"Kao SC, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, van Zandwijk N, et al. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res. 2010;16(23):5805\u201313.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1889_CR10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.juro.2010.05.028","volume":"184","author":"Y Ohno","year":"2010","unstructured":"Ohno Y, Nakashima J, Ohori M, Hatano T, Tachibana M. Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. J Urol. 2010;184(3):873\u20138.","journal-title":"J Urol"},{"issue":"4","key":"1889_CR11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","volume":"64","author":"M Babjuk","year":"2013","unstructured":"Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Comp\u00e9rat E, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol. 2013;64(4):639\u201353.","journal-title":"Eur Urol"},{"issue":"5","key":"1889_CR12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF01741551","volume":"34","author":"EC Boer De","year":"1992","unstructured":"De Boer EC, De Jong WH, Steerenberg PA, Aarden LA, Tetteroo E, De Groot ER, et al. Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Gu\u00e9rin in superficial bladder cancer. Cancer Immunol Immunother. 1992;34(5):306\u201312.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"1889_CR13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2249.1999.00756.x","volume":"115","author":"K Taniguchi","year":"1999","unstructured":"Taniguchi K, Koga S, Nishikido M, Yamashita S, Sakuragi T, Kanetake H, et al. Systemic immune response after intravesical instillation of bacille Calmette-Gu\u00e9rin (BCG) for superficial bladder cancer. Clin Exp Immunol. 1999;115(1):131\u20135.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"1889_CR14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883\u201399.","journal-title":"Cell"},{"issue":"6917","key":"1889_CR15","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860\u20137.","journal-title":"Nature"},{"issue":"15","key":"1889_CR16","first-page":"3438","volume":"55","author":"M Tachibana","year":"1995","unstructured":"Tachibana M, Miyakawa A, Tazaki H, Nakamura K, Kubo A, Hata J, et al. Autocrine growth of transitional cell carcinoma of the bladder induced by granulocyte-colony stimulating factor. Cancer Res. 1995;55(15):3438\u201343.","journal-title":"Cancer Res"},{"issue":"5","key":"1889_CR17","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.urology.2011.11.070","volume":"79","author":"T Gondo","year":"2012","unstructured":"Gondo T, Nakashima J, Ohno Y, Choichiro O, Horiguchi Y, Namiki K, et al. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. Urology. 2012;79(5):1085\u201391.","journal-title":"Urology"},{"issue":"6","key":"1889_CR18","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.juro.2013.06.082","volume":"190","author":"M Martino de","year":"2013","unstructured":"de Martino M, Pantuck AJ, Hofbauer S, Waldert M, Shariat SF, Belldegrun AS, et al. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma. J Urol. 2013;190(6):1999\u20132004.","journal-title":"J Urol"},{"key":"1889_CR19","author":"O Dalpiaz","year":"2013","unstructured":"Dalpiaz O, Ehrlich GC, Mannweiler S, Hern\u00e1ndez JM, Gerger A, Stojakovic T, et al. Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma. BJU Int. 2013. doi: 10.1111\/bju.12441 .","journal-title":"BJU Int"},{"issue":"2","key":"1889_CR20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02893372","volume":"11","author":"S Bircan","year":"2005","unstructured":"Bircan S, Candir O, Kapucuoglu N. The effect of tumor invasion patterns on pathologic stage of bladder urothelial carcinomas. Pathol Oncol Res. 2005;11(2):87\u201391.","journal-title":"Pathol Oncol Res"},{"issue":"4","key":"1889_CR21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1159\/000343278","volume":"89","author":"C Can","year":"2012","unstructured":"Can C, Baseskioglu B, Y\u0131lmaz M, Colak E, Ozen A, Yenilmez A. Pretreatment parameters obtained from peripheral blood sample predicts invasiveness of bladder carcinoma. Urol Int. 2012;89(4):468\u201372.","journal-title":"Urol Int"},{"issue":"4","key":"1889_CR22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3802\/jgo.2012.23.4.265","volume":"23","author":"S Raungkaewmanee","year":"2012","unstructured":"Raungkaewmanee S, Tangjitgamol S, Manusirivithaya S, Srijaipracharoen S, Thavaramara T. Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer. J Gynecol Oncol. 2012;23(4):265\u201373.","journal-title":"J Gynecol Oncol"},{"issue":"3","key":"1889_CR23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.clgc.2013.04.003","volume":"11","author":"T Azuma","year":"2013","unstructured":"Azuma T, Matayoshi Y, Odani K, Sato Y, Sato Y, Nagase Y, et al. Preoperative neutrophil-lymphocyte ratio as an independent prognostic marker for patients with upper urinary tract urothelial carcinoma. Clin Genitourin Cancer. 2013;11(3):337\u201341.","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"1889_CR24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","volume":"88","author":"GJ Guthrie","year":"2013","unstructured":"Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88(1):218\u201330.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1889_CR25","doi-asserted-by":"crossref","unstructured":"Schiffer E, Vlahou A, Petrolekas A, Stravodimos K, Tauber R, Geschwend JE, et al. Prediction of muscle-invasive bladder cancer using urinary proteomics. Clin Cancer Res. 2009;15(15):4935\u201343.","DOI":"10.1158\/1078-0432.CCR-09-0226"},{"issue":"6","key":"1889_CR26","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/1097-0142(19940315)73:6<1708::AID-CNCR2820730626>3.0.CO;2-J","volume":"73","author":"JB Thrasher","year":"1994","unstructured":"Thrasher JB, Frazier HA, Robertson JE, Dodge RK, Paulson DF. Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer. 1994;73(6):1708\u201315.","journal-title":"Cancer"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-1889-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-014-1889-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-1889-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:27:00Z","timestamp":1559489220000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-014-1889-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,3]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["1889"],"URL":"https:\/\/doi.org\/10.1007\/s13277-014-1889-x","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,3]]}}}